Brought to you by 
Eisai signs CNS drug discovery alliance with Johns Hopkins
21 Jun 2017
Executive Summary
In their second deal together in as many years, Eisai Co. Ltd. and Johns Hopkins University’s Brain Science Institute will collaborate on neurological drug discovery over the next five years with the goal of identifying therapeutics that directly address the underlying causes of certain disorders.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Eisai signs CNS drug discovery alliance with Johns Hopkins
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice